T CELL SCIENCES, INC.

Company

Celldex Therapeutics, Inc.

Filed

April 15, 1996

Period of Report

May 21, 1996

Accession Number

0000950135-96-001733

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →